Dihydrocaffeic acid
Code | Size | Price |
---|
TAR-T0539-1mL | 1 mL * 10 mM (in DMSO) | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0539-50mg | 50mg | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Dihydrocaffeic Acid is a natural product containing a catechol group with an α,β-unsaturated carboxylic acid chain. Dihydrocaffeic Acid has been shown to have hepatoprotective activity. Dihydrocaffeic Acid is a metabolite of Caffeic Acid with potent antioxidant properties.
CAS:
1078-61-1
Formula:
C9H10O4
Molecular Weight:
182.175
Pathway:
Metabolism; oxidation-reduction; MAPK
Purity:
0.9945
SMILES:
OC(=O)CCc1ccc(O)c(O)c1
Target:
Antioxidant; p38 MAPK; Endogenous Metabolite
References
1. P?rez-Alvarez V, et al. Structure-hepatoprotective activity relationship of 3,4-dihydroxycinnamic acid (caffeic acid) derivatives. J Appl Toxicol. 2001 Nov-Dec;21(6):527-31.
2. Huang J, et al. Antioxidant effects of dihydrocaffeic acid in human EA.hy926 endothelial cells. J Nutr Biochem. 2004 Dec;15(12):722-9.
3. Poquet L, et al. Investigation of the metabolic fate of dihydrocaffeic acid. Biochem Pharmacol. 2008 Mar 1;75(5):1218-29.
4. Aoki R, et al. J Neurosci. 2011 Nov 16; 31(46): 16603-10.